Lisinopril reduces postexercise albuminuria more effectively than atenolol in primary hypertension

European Journal of Clinical Pharmacology

Volumn 49, Issue 4, 1996, Pages 267-271

  Rangemark C ^a   Lind, H ^b   Lindholm, L ^b   Hedner, T ^a   Samuelsson, O ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

ACE inhibition; Atenolol; Exercise; Hypertension; Lisinopril; Urinary albumin excretion; blockade

Indexed keywords

ATENOLOL; LISINOPRIL; PLACEBO;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EXERCISE; FEMALE; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0030032517     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf00226326     Document Type: Article

References (43)

1. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A (1989) Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32: 219-226
2. Shearman CP, Gosling P (1988) Microalbuminuria and vascular permeability. Lancet 11:906-907
3. Rambauske M, Fliser D, Ritz E (1992) Albuminuria of hypertensive patients. Clin Nephrol 38 [Suppl 1]:S40-S45
4. Samuelsson O, Hedner T, Ljungman S, Herlitz H, Widgren B, Pennert K (1992) A comparative study of lisinopril and atenolol on low degree urinary albumin excretion, renal function and haemodynamics in uncomplicated, primary hypertension. Eur J Clin Pharmacol 43:469-475
5. Kannel WB, Stampfer MJ, Castelli WP, Vester J (1984) The prognostic significance of proteinuria: the Framingham study. Am Heart J 108:1347-1352
6. Samuelsson O (1988) Proteinuria as a prognostic factor during long-term antihypertensive care. Drugs 35 [Suppl 5]:48-54
7. Mogensen CE (1984) Microalbuminuria predicts clinical proteinurina and early mortality in maturity-onset diabetes. N Engl J Med 310:356-360
8. Mattock MB, Keen H, Viberti GC, et al (1988) Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 31:82-87
9. Yudkin JS, Forrest RD, Jackson CA (1988) Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet 11:530-533
10. Ljungman S (1990) The role of microalbuminuria in essential hypertension. Am J Hypertens 3:956-960
11. Damsgaard EM, Froland A, Jørgensen OD, Mogensen CE (1992) Eight to nine years' mortality in known non-insulin dependent diabetics and controls. Kidney Int 41:731-735
12. de Jong PE, Anderson S, de Zeeuw D (1993) Glomerular preload and afterload reduction as a tool to lower urinary protein leakage: will such treatments also help to improve renal function outcome? J Am Soc Nephrol 3:1333-1341
13. de Venuto G, Andreotti C, Mattarei M, Pegoretti G (1985) Long-term captopril therapy at low doses reduces albumin excretion in patients with essential hypertension and no signs of renal impairment. J Hypertens 3 [Suppl 2]:143-145
14. Poortmans JR, Rampaaer L, Wolfs J-C (1989) Renal protein excretion after exercise in man. Eur J Appl Physiol 58:476-480
15. Esnault VLM, Poitron-Josse M, Testa A, Ginet JD, Le Carrer D, Guenel J (1991) Captopril but not acebutolol, prazosin or indomethacin decreases postexercise proteinuria. Nephron 58:437-442
16. Christensen CK, Krusell LR (1987) Acute and long-term effect of antihypertensive treatment on exercise induced microalbuminuria in essential hypertension. J Clin Hypertens 3:704-712
17. Romanelli G, Giustina A, Agabiti-Rosei E, Bossoni S, Girelli A, Muiesan ML, Moisen G, Giostina G (1989) Short-term effect of captopril and nifedipine on microalbuminuria induced by exercise in hypertensive diabetic patients. J Hypertens 6 [Suppl 6]:S312-S313
18. Torffvit O, Castenfors J, Agardh C-D (1991) A study of exercise-induced microalbuminuria in type I (insulin-dependent) diabetes mellitus. Scand J Urol Nephrol 25:39-43
19. Gosling D, Beevers DG (1989) Urinary albumin excretion and blood pressure in the general population. Clin Sci 76:39-42
20. Gianconi S, Levanti C, Fommei E, Innocenti F, Seghieri G, Palla L, Palombo C, Buione S (1989) Microalbuminuria and causal and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension. Am J Hypertens 2:259-261
21. Montagna B, Buzio C, Calderini C, Quaretti P, Migone L (1983) Relationship of proteinuria and albuminuria to posture and urine collection period. Nephron 35:143-144
22. West JN, Gosling P, Dimmitt SB, Littler WA (1991) Non-diabetic microalbuminuria in clinical practice and its relationship to posture, exercise and blood pressure. Clin Sci 81 3: 373-377
23. 2-microglobulin in young patients with mild essential hypertension without treatment and during long-term propranolol treatment. Scand J Lab Invest 41: 493-498
24. Yamada T, Iscihara M, Ishikawa K, Hiramato K (1980) Protenuria and renal function during antihypertensive treatment for essential hypertension. J Am Geriatr Soc 28:114-117
25. Parving HH, Jensen HA, Westrup M (1977) Increased transcapillary escape rate of albumin and IgG in essential hypertension. Scand J Lab Invest 37:223-227
26. Marre M, LeBlanc H, Suarez L, Guyenne TT, Menard J, Passa P (1987) Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. BMJ 294:1448-1452
27. Andersen S, Rennke HG, Brenner BM (1986) Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77:1993-2000
28. Jackson B, Johnston C (1988) The contribution of systemic hypertension to progression of chronic renal failure in the rat remnant kidney: effect of treatment with an angiotensin converting enzyme inhibitor or a calcium inhibitor. J Hypertens 6:495-501
29. Hallab M, Gallois Y, Chatellier G, Rohmer V, Fressinaud P, Marre M (1993) Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes mellitus. BMJ 306:175-82
30. Hall JE (1986) Regulation of glomerular filtration rate and sodium excretion by angiotensin II. Fed Proc 45:1431-1437
31. Kanwar YS (1984) Biology of disease. Biophysiology of glomerular filtration and proteinuria. Lab Invest 51:7-2l
32. Brunner HR, Waeber B, Nussberger J (1987) Renal effects of converting enzyme inhibition. J Cardiovasc Pharmacol 9 [Suppl 3]:S6-S14
33. Morelli E (1990) Effects of converting enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 39:76-82
34. Raij L, Keane WF (1985) Glomerular mesangium: its function and relationship to angiotensin II. Am J Med 79 [Suppl 3C]:24-30
35. Castenfors J (1967) Renal function during exercise. Acta Physiol Scand 293(Suppl 70):1-44
36. Staessen J, Fagard R, Hespel P, Lijnen P, Vanhmees L, Amery A (1987) Plasma renin system during exercise in normal men. J Appl Physiol 63:188-194
37. Mittleman KD, Zambraski EJ (1992) Exercise-induced proteinuria is attenuated by indomethacin. Med Sci Sports Exerc 24:1069-1074
38. Rudberg S, Sätterström G, Dahlqvist R, Dahlquist G (1993) Indomethacin but not metoprolol reduces exercise-induced albumin excretion rate in type I diabetic patients with microalbuminuria. Diab Med 10:460-464
39. Viberti GC (1992) Introduction to a structural basis for renal and vascular complications in diabetes and hypertension. J Hypertens 10 [Suppl 1]:S1-S4
40. Parving HH, Nielsen SL, Larsen NA (1974) Increased transcapillary escape rate of albumin, IgG, and IgM during angiotensin-II-induced hypertension in man. Scand J Lab Invest 34:111-118
41. Dzau VJ (1989) Multiple pathways of angiotensin production in the blood vessel wall: evidence, possibilities and hypothesis. J Hypertens 7:933-936
42. Unger T, Gohlke P (1990) Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors. Am J Cardiol 65:31-101
43. Chobanian AV, Handenschild CC, Nickerson C, Drago R (1990) Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension 15:327-331